Literature DB >> 33473123

Distinct mechanisms control genome recognition by p53 at its target genes linked to different cell fates.

Marina Farkas1, Hideharu Hashimoto1, Yingtao Bi2, Ramana V Davuluri2, Lois Resnick-Silverman3, James J Manfredi3, Erik W Debler1, Steven B McMahon4.   

Abstract

The tumor suppressor p53 integrates stress response pathways by selectively engaging one of several potential transcriptomes, thereby triggering cell fate decisions (e.g., cell cycle arrest, apoptosis). Foundational to this process is the binding of tetrameric p53 to 20-bp response elements (REs) in the genome (RRRCWWGYYYN0-13RRRCWWGYYY). In general, REs at cell cycle arrest targets (e.g. p21) are of higher affinity than those at apoptosis targets (e.g., BAX). However, the RE sequence code underlying selectivity remains undeciphered. Here, we identify molecular mechanisms mediating p53 binding to high- and low-affinity REs by showing that key determinants of the code are embedded in the DNA shape. We further demonstrate that differences in minor/major groove widths, encoded by G/C or A/T bp content at positions 3, 8, 13, and 18 in the RE, determine distinct p53 DNA-binding modes by inducing different Arg248 and Lys120 conformations and interactions. The predictive capacity of this code was confirmed in vivo using genome editing at the BAX RE to interconvert the DNA-binding modes, transcription pattern, and cell fate outcome.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33473123      PMCID: PMC7817693          DOI: 10.1038/s41467-020-20783-z

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   17.694


  49 in total

1.  3DNA: a software package for the analysis, rebuilding and visualization of three-dimensional nucleic acid structures.

Authors:  Xiang-Jun Lu; Wilma K Olson
Journal:  Nucleic Acids Res       Date:  2003-09-01       Impact factor: 16.971

2.  Structure of p73 DNA-binding domain tetramer modulates p73 transactivation.

Authors:  Abdul S Ethayathulla; Pui-Wah Tse; Paola Monti; Sonha Nguyen; Alberto Inga; Gilberto Fronza; Hector Viadiu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-02       Impact factor: 11.205

3.  Disparate levels of beta-catenin activity determine nephron progenitor cell fate.

Authors:  Harini Ramalingam; Alicia R Fessler; Amrita Das; M Todd Valerius; Jeannine Basta; Lynn Robbins; Aaron C Brown; Leif Oxburgh; Andrew P McMahon; Michael Rauchman; Thomas J Carroll
Journal:  Dev Biol       Date:  2018-04-26       Impact factor: 3.582

4.  Identification of a novel class of genomic DNA-binding sites suggests a mechanism for selectivity in target gene activation by the tumor suppressor protein p53.

Authors:  L Resnick-Silverman; S St Clair; M Maurer; K Zhao; J J Manfredi
Journal:  Genes Dev       Date:  1998-07-15       Impact factor: 11.361

5.  An induced fit mechanism regulates p53 DNA binding kinetics to confer sequence specificity.

Authors:  Tom J Petty; Soheila Emamzadah; Lorenzo Costantino; Irina Petkova; Elena S Stavridi; Jeffery G Saven; Eric Vauthey; Thanos D Halazonetis
Journal:  EMBO J       Date:  2011-04-26       Impact factor: 11.598

Review 6.  The first 30 years of p53: growing ever more complex.

Authors:  Arnold J Levine; Moshe Oren
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

7.  ChIP-seq: using high-throughput sequencing to discover protein-DNA interactions.

Authors:  Dominic Schmidt; Michael D Wilson; Christiana Spyrou; Gordon D Brown; James Hadfield; Duncan T Odom
Journal:  Methods       Date:  2009-03-09       Impact factor: 3.608

8.  A rare DNA contact mutation in cancer confers p53 gain-of-function and tumor cell survival via TNFAIP8 induction.

Authors:  Jessica A Monteith; Hestia Mellert; Morgan A Sammons; Laudita A Kuswanto; Stephen M Sykes; Lois Resnick-Silverman; James J Manfredi; Shelley L Berger; Steven B McMahon
Journal:  Mol Oncol       Date:  2016-06-07       Impact factor: 6.603

Review 9.  Putting p53 in Context.

Authors:  Edward R Kastenhuber; Scott W Lowe
Journal:  Cell       Date:  2017-09-07       Impact factor: 41.582

10.  Mapping the structural and dynamical features of multiple p53 DNA binding domains: insights into loop 1 intrinsic dynamics.

Authors:  Suryani Lukman; David P Lane; Chandra S Verma
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

View more
  7 in total

1.  Unlocking p53 response elements: DNA shape is the key.

Authors:  Marina Farkas; Steven McMahon
Journal:  Mol Cell Oncol       Date:  2021-04-22

Review 2.  Adaptive homeostasis and the p53 isoform network.

Authors:  Sunali Mehta; Hamish Campbell; Catherine J Drummond; Kunyu Li; Kaisha Murray; Tania Slatter; Jean-Christophe Bourdon; Antony W Braithwaite
Journal:  EMBO Rep       Date:  2021-11-15       Impact factor: 8.807

Review 3.  It's Getting Complicated-A Fresh Look at p53-MDM2-ARF Triangle in Tumorigenesis and Cancer Therapy.

Authors:  Che-Pei Kung; Jason D Weber
Journal:  Front Cell Dev Biol       Date:  2022-01-26

4.  Time-series transcriptomics and proteomics reveal alternative modes to decode p53 oscillations.

Authors:  Alba Jiménez; Dan Lu; Marian Kalocsay; Matthew J Berberich; Petra Balbi; Ashwini Jambhekar; Galit Lahav
Journal:  Mol Syst Biol       Date:  2022-03       Impact factor: 11.429

5.  Structural Basis of Mutation-Dependent p53 Tetramerization Deficiency.

Authors:  Marta Rigoli; Giovanni Spagnolli; Giulia Lorengo; Paola Monti; Raffaello Potestio; Emiliano Biasini; Alberto Inga
Journal:  Int J Mol Sci       Date:  2022-07-19       Impact factor: 6.208

6.  ROS-activated CXCR2+ neutrophils recruited by CXCL1 delay denervated skeletal muscle atrophy and undergo P53-mediated apoptosis.

Authors:  Yaoxian Xiang; Junxi Dai; Yao Li; Zongqi You; Junpeng Zhang; Xinying Huang; Shuqi Nie; Yujie Chen; Lei Xu; Fengming Liu; Junjian Jiang; Jianguang Xu
Journal:  Exp Mol Med       Date:  2022-07-21       Impact factor: 12.153

7.  Generation and Characterization of Site-Specifically Mono-Ubiquitylated p53.

Authors:  Alexandra Julier; Vanessa Radtke; Andreas Marx; Martin Scheffner
Journal:  Chembiochem       Date:  2022-02-03       Impact factor: 3.461

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.